FDA Clearance for 23andMe genetic test on Hereditary Prostate Cancer Marker
The clearance allows 23andMe to report on the G84E mutation in the HOXB13 gene, cli…
23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
Gartner’s 2022 technology trends predictions and how they reflect to healthcare industry
Gartner just recently introduced their top strategic technology trends for 2022. Th…
Vayyar to provide fall detection powered by touchless technology compatible with new Amazon Alexa Together service
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to…
Vinehealth: $5.5 million of investment to launch in the US
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app…
Women’s Health: WHO launches a chatbot with messaging on breast cancer
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot t…
Pear Therapeutics goes public on Nasdaq as Pear
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the…
PrecisionOS: approved by FDA to market VR surgical planning tool
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administra…
Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-base…
Novel algorithm on wearable devices can detect irregular heartbeat, may prompt early care
Research Highlights: A novel software algorithm developed for wearable devices, …